First-in-human data for the trispecific antibody “suggest a paradigm shift” for the relapsed/refractory multiple myeloma ...

We treated 428 patients who had active rheumatoid arthritis despite methotrexate therapy with placebo or infliximab, a chimeric monoclonal antibody against TNF-α, in intravenous doses of 3 or 10 ...

Monoclonal antibodies might help to elucidate the pathogenesis ... with other immunosuppressive therapies. Rituximab is a chimeric mAb that targets the CD20 antigen on B cells and induces cell ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

Market Size and Growth: Analysis of the current market size and projections for the cancer monoclonal antibody market from 2023 to 2032. This includes data on market value and volume, as well as the ...

Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a ...